Experimental Oncology, 2015 (том 37) http://dspace.nbuv.gov.ua:80/handle/123456789/133163 2026-04-18T21:26:49Z 2026-04-18T21:26:49Z Acknowledgement http://dspace.nbuv.gov.ua:80/handle/123456789/145717 2019-01-27T23:23:16Z 2015-01-01T00:00:00Z Acknowledgement 2015-01-01T00:00:00Z Subject index to volume 37 (2015) http://dspace.nbuv.gov.ua:80/handle/123456789/145716 2019-01-27T23:23:14Z 2015-01-01T00:00:00Z Subject index to volume 37 (2015) 2015-01-01T00:00:00Z Authors index to volume 37 (2015) http://dspace.nbuv.gov.ua:80/handle/123456789/145715 2019-01-27T23:23:12Z 2015-01-01T00:00:00Z Authors index to volume 37 (2015) 2015-01-01T00:00:00Z Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy Lakota, J. Gocarova, K. Spanik, S. http://dspace.nbuv.gov.ua:80/handle/123456789/145561 2019-01-23T23:23:20Z 2015-01-01T00:00:00Z Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy Lakota, J.; Gocarova, K.; Spanik, S. This is a clinical observation of a patient treated for metastatic head and neck cancer with mesenchymal stem cells mediated prodrug gene therapy. The cells were applied intravenously. We did not observe any therapeutic effect. However, a temporal bicytopenia was observed. Key Words: metastatic head and neck cancer, therapeutic stem cells, blood counts. 2015-01-01T00:00:00Z